कोशिश गोल्ड - मुक्त
America is Hooked on Antidepressants
Newsweek US
|September 30, 2022
Popular medications work no better than placebo for millions of Americans and can come with severe withdrawal symptoms. Why do doctors prescribe them to 43 million Americans?
Five years ago Mark Horowitz seemed an unlikely skeptic of psycho-pharmaceuticals. He had been taking the popular antidepressant Lexapro virtually every day for 15 years. He was so fascinated by the drugs that he spent three years hunched over a dish of human brain cells in a laboratory at King's College London, measuring the effect of human stress hormones and drugs like Prozac and Zoloft.
Then, when he tried to wean himself off the medication, he suffered panic attacks, sleep disruptions and a depression so debilitating that he had to move back to his parents' house in Australia-symptoms that he says were far worse than anything he experienced prior to going on the drugs. He went online and found thousands of others in a similar pickle. They had been unable to kick one of the psychiatric drugs known as Selective Serotonin Reuptake Inhibitors, or SSRIs, which include Lexapro, Zoloft and Prozac, among others. Since withdrawal symptoms were thought to be mild and temporary, many of them, like him, had been told by doctors that they were experiencing a relapse of their depression. The experience galvanized Horowitz to dig deeper into the claims that pharmaceutical companies, and the scientists they fund, have been making about these popular antidepressants.
Hailed as a revolution for the treatment of depression when they first came out in the 1980s, SSRIs have become a mainstay of mental health treatment. Family doctors with little psychiatric training now prescribe them for adults and children alike. In 2019, one in eight Americans-43 million in all-were taking an SSRI, and those numbers have likely risen among a public ridden with COVID-induced anxiety. During the pandemic, doctors phoned in so many new prescriptions for Zoloft, the FDA warned of a drug shortage.
यह कहानी Newsweek US के September 30, 2022 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Newsweek US से और कहानियाँ
Newsweek US
WILL SHARPE
The actor has been on a roll since White Lotus, and his latest role as Wolfgang Amadeus Mozart in the Starz limited series Amadeus may be his “most exciting challenge” yet
2 mins
July 03, 2026
Newsweek US
From Root to Tree
As executive producer, Brooke Shields had her hand in everything on You're Killing Me
1 min
July 03, 2026
Newsweek US
SHINMEI Strengthens Japan's Food Security Globally
SHINMEI Holdings is linking overseas demand for Japanese food with domestic agricultural renewal, using innovation, exports and producer support to strengthen Japan's food security.
4 mins
July 03, 2026
Newsweek US
UNCOMMON KNOWLEDGE Emperor's New Clothes
President Donald Trump marked his 80th birthday by turning the White House into a fight venue-prompting familiar Roman emperor comparisons.
1 mins
July 03, 2026
Newsweek US
From Shinkansen Icon to Global Sensation: Bringing Japan’s Premium Ice Cream Experience to the World
Sujahta Meiraku aims to export the premium quality and unique experience of its signature “Shinkansen ice cream” through tourism-driven retail and experiential dessert concepts worldwide.
4 mins
July 03, 2026
Newsweek US
A Victory off the Pitch
China didn't qualify for the FIFA World Cup, but that hasn't stopped its brands performing.
1 min
July 03, 2026
Newsweek US
Socials Win Clicks as Trust Takes a Hit
The numbers tell a striking story-and hint at a deeper shift in how people relate to news.
1 min
July 03, 2026
Newsweek US
ANSWERING THE CALL
With theatrical rom-coms nearly extinct, Netflix is finding success building the genre’s new home
2 mins
July 03, 2026
Newsweek US
The Feed Doesn't Follow House Rules
A parent can pick up their kid's phone and find an impossible assignment waiting: monitor every app, feed, stranger, algorithmic nudge, sleepless doomscroll.
1 min
July 03, 2026
Newsweek US
RUFFLED FEATHERS
A $1.4 billion Jared Kushner-backed resort is putting Albania’s EU ambitions, its rule of law and its flamingos on the line
5 mins
July 03, 2026
Translate
Change font size
